First published on 08 Jan 2021
A joint statement from British Society of Gastroenterology, British Association for the Study of the Liver, NHS Blood & Transplant and British Liver Trust Patients with liver disease that are considered to be clinically extremely vulnerable are at increased risk […]
First published on 28 Oct 2020
This document was first published in October 2020, and reviewed in January 2021 The incidence of HCC in patients with compensated cirrhosis is 1-2% per year. NICE recommends offering HCC surveillance to patients with cirrhosis and to selected patients with […]
First published on 09 Jul 2020
This guidance represents the professional advice from the British Association for the Study of the Liver, British Society of Gastroenterology, British Transplantation Society, NHS Blood & Transplant and input from the British Liver Trust. The patients in the groups below […]
First published on 03 Jun 2020
Salvage TIPSS service provision during the COVID-19 outbreak Salvage TIPSS in patients with variceal haemorrhage refractory to endoscopic/drug therapy is associated with a 60% 1-year survival (>70% in Child’s Pugh A/B) and is recommended in Child’s Pugh Score ≤13 (1,2). […]
First published on 10 Apr 2020
The government previously had asked patients receiving immunosuppression for a liver transplant or autoimmune hepatitis to be shielded. As no central register exists for patients with autoimmune hepatitis on immunosuppressive medications, individual hospitals with the help of specialists have been […]